Key academic publications

: Colour photograph of the back of the right eye. The pale region on the right is the optic nerve head. Blood vessels fan out from here across the retina. The background is a pink hue. The dark spot in the centre is the fovea, the area of maximum focus. This picture represents a healthy eye.

Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials

: Colour photograph of the back of the right eye. The pale region on the right is the optic nerve head. Blood vessels fan out from here across the retina. The background is a pink hue. The dark spot in the centre is the fovea, the area of maximum focus. This picture represents a healthy eye.

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia

: Colour photograph of the back of the right eye. The pale region on the right is the optic nerve head. Blood vessels fan out from here across the retina. The background is a pink hue. The dark spot in the centre is the fovea, the area of maximum focus. This picture represents a healthy eye.

Outcome Measures Used in Ocular Gene Therapy Trials: A Scoping Review of Current Practice

: Colour photograph of the back of the right eye. The pale region on the right is the optic nerve head. Blood vessels fan out from here across the retina. The background is a pink hue. The dark spot in the centre is the fovea, the area of maximum focus. This picture represents a healthy eye.

The elephant in the room: understanding the pathogenesis of Charles Bonnet syndrome

: Colour photograph of the back of the right eye. The pale region on the right is the optic nerve head. Blood vessels fan out from here across the retina. The background is a pink hue. The dark spot in the centre is the fovea, the area of maximum focus. This picture represents a healthy eye.

ISCEV and IPS guideline for the full-field stimulus test (FST)

Harmonization of Outcomes and Vision Endpoints in Vision Restoration Trials: Recommendations from the International HOVER Taskforce

Low Luminance Visual Acuity and Low Luminance Deficit in Choroideremia and RPGR-Associated Retinitis Pigmentosa

Scotopic microperimetry: evolution, applications and future directions



Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies


Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center

Google Scholar Profile

Recordings from talks

Clinical Trials

Podcast about getting involved in clinical research

Presented to The Choroideremia Research Foundation May 2022 How do we measure choroideremia?

Presented to Support for Sight January 2022 Research advances in genetic eye disease

Presented to Support for Sight August 2022 Alternatives to gene therapy

Demonstration of electronic visual acuity

How the eyes and the brain are connected.

Low Vision

Presented at Hospital Optometrists Annual Conference 2016 Guide to giving bad news

Presented to Macular Disease Society August 2023 Charles Bonnet Syndrome background and new insights

Presented to Retina UK professionals conference July 2023

Introduction to FrACT

Teaching

Presented to Learn Beyond Vision December 2022 Low Vision Service For All: The UK Model.

Presented to Mero Eye June 2021 Writing a peer reviewed paper

Presented to Mero Eye December 2020 Importance of multidisciplinary research

Articles

The Final Piece of the Puzzle

How Jasleen Jolly and her collaborators are currently combining ophthalmology and neuroscience to determine the cause of Charles Bonnet Syndrome

Bring Down the Walls

Incorporating different voices, disciplines, and areas of knowledge are key to breaking down the hierarchies that prevent successful collaboration

Words May Hurt Me

How communication of vision loss diagnoses can impact patients’ psychological health in the long term

Short REPORT ERN-EYE

5th Scientific Workshop

Barriers to academic–clinician collaborations

A Shared Vision

Five eye care experts present their views on the growing need for effective collaboration between ophthalmologists and optometrists – and practitioners from other disciplines

EDI

Immune System Disorders in the Workplace.

Diversity and inclusion in STEM

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

error: Content is protected !!
Scroll to Top